CardioNet has announced new features for its cardiac remote monitoring and diagnostic MCOT system that give physicians more in-depth data. The new features will help physicians better diagnose atrial fibrillation, heart pauses, and ventricular tachycardia.
The company stated that the new features can be used in conjunction with CardioNet's SomNet program to help identify indications of sleep...
CardioNet's Director of Business Development Aaron Goldmuntz laid out his company's growth strategy during a presentation this morning at Qualcomm's Smart Services Leadership Summit here in San Diego. Immediate opportunities for growth, Goldmuntz said, included leveraging CardioNet's platform to develop additional applications that relate to atrial fibrillation. Adjacent markets could include...
CardioNet, the only pure play wireless health company that has gone public, began selling a sleep disorders clinical indicator, called SomNet. The company believes that SomNet has the potential to identify patients with a high likelihood of sleep disorders by measuring cyclic variation of heart rate (CVHR), a rhythm that is caused by repeated arousals from sleep because of the disorders.
"There...
